Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
11/2007
11/22/2007US20070270482 Cytotoxic Agents Comprising New C-2 Modified Taxanes
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270421 Hepatocyte growth factor receptor inhibitors; Antitumor agents, anticarcinogenic agents, angiogenesis inhibitors; pyrimidine derivatives like Pyrrolidine-1-carboxylic acid [6-(2-fluoro-4-{3-[2-(4-fluorophenyl)acetyl]thioureido}phenoxy)pyrimidin-4-yl]amide
11/22/2007CA2652705A1 Dioxaspiroketal derivatives, process for their preparation and uses thereof
11/22/2007CA2652101A1 New heterocyclic compounds for the inhibition of integrins and use thereof
11/21/2007EP1856111A1 Purification of mupirocin
11/21/2007EP1761524B1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
11/20/2007US7297714 Inhibitors of cathepsin S
11/20/2007US7297696 Antiarthritic agents; antihistamines; atherosclerosis; multiple sclerosis; Crohn's disease; nephritis; pancreastitis; skin disorders; restenosis; prevent leukocyte migration
11/20/2007US7297694 central nervous system disorders; traumas; anticancer agents; neurodegenerative agents; analgesics; headaches and cardiovascular disorders
11/20/2007US7297693 furan-, pyrrole- or thiophenecarboxamides ring-substituted with a hydroxyimino-fused ring and a nitrogen heteroarene; e.g., 5-[5-(1-Morpholin-4-yl-methanoyl)-2-pyridin-4-yl-furan-3-yl]-indan-1-one oxime;treating neurotraumatic diseases, cancer, neurodegeneration, pain, migraine and cardiac hypertrophy
11/15/2007WO2007128492A1 Novel pharmaceutical compositions
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007CA2649882A1 Novel pharmaceutical compositions
11/14/2007EP1854789A1 Quinazoline derivative having tyrosine kinase inhibitory activity
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1565442B1 Pyridine derivatives as cb2 receptor modulators
11/14/2007CN101072773A Pyrrole derivatives having CRTH2 receptor antagonist activity
11/14/2007CN101070317A Heterocyclic derivatives, composition containing same and method for pests control
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN101070308A Isoxazoline derivative and its use
11/14/2007CN100348592C 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method
11/14/2007CN100348580C Taxol enhancer compounds
11/13/2007US7294635 Substituted isoquinolinones
11/13/2007CA2248304C Surface modified carbonate materials
11/08/2007WO2007107470A3 Pyrazoles as 11-beta-hsd-1
11/08/2007WO2007054105A3 Method for the preparation of escitalopram
11/08/2007CA2646474A1 Processes for the synthesis of 3-isobutylglutaric acid
11/06/2007US7291352 Nut extract having different alkaloid profile; reduced level of carcinogens; supercritical CO2 extraction; maintaining nutraceutical effects; rapidly dissolving tablets
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007123953A2 Phosphodiesterase 4 inhibitors
11/01/2007WO2007061923A3 Glucokinase activators
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
10/2007
10/31/2007EP1848711A1 Fungicidal pyrazine derivatives
10/31/2007CN101062919A 4-methyl-1H-diaryl pyrromonazole derivative and medicament usage thereof
10/31/2007CN100345842C Dimeric compounds and their use as anti-viral agents
10/30/2007US7288564 Analgesics, antiinflammatory agents, autoimmune diseases, bone disorders, central nervous system disorders
10/30/2007US7288543 Opioid receptor antagonists
10/25/2007WO2007121389A2 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors
10/25/2007US20070249708 C7 ester and c10 hydroxy substituted taxanes
10/25/2007US20070249707 Taxanes having c7 hydroxy and c10 heterosubstituted acetate substituents
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/24/2007EP1846387A2 Bis-(coumarin) compounds with anti-inflammatory activity
10/24/2007CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors
10/24/2007CN101058558A 4-Oxy-1(4H)-quinoline carboxylic acids compound and composition with aldose reductase inhibition activity and preparation method thereof
10/23/2007US7285662 Therapeutic heterocyclic compounds
10/23/2007US7285549 Sulfamides and their use as endothelin receptor antagonists
10/18/2007WO2007117165A1 New pharmaceutical compounds
10/18/2007WO2007117161A1 Substituted ring fused azines and their use in cancer therapy
10/18/2007WO2007115695A1 Diamino-1 ,3,5-triazines n-substituted with bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators
10/18/2007WO2005037780A3 Amidomethyl-substituted 2-(4-sulfonilamino)-3-hidroxy-3,4-dihydro-2h-chromium-6-yl-derivatives and drugs containing said compounds
10/18/2007US20070244187 Intermediates for the Preparation of Halichondrin B
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007CA2649021A1 Diamino-1,3,5-triazines n-substituted with bicyclic radicals, process for their preparation, compositions thereof, and their use as herbicides and plant growth regulators
10/18/2007CA2648914A1 Pyridyloxadiazole substituted compounds and compositions
10/18/2007CA2648323A1 Substituted ring fused azines and their use in cancer therapy
10/17/2007EP1843820A1 Multicyclic bis-amide mmp inhibitors
10/16/2007US7282510 neurotrophic N-glyoxyl-prolyl ester compounds e.g. (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidine carboxylic acid; non-immunosuppressive; side effect reduction; neurodegenerative diseases
10/11/2007WO2007114475A1 Cocrystal of c-glycoside derivative and l-proline
10/11/2007WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
10/11/2007WO2007113289A1 Benzofuran compounds as ep1 receptor antagonists
10/11/2007US20070238729 Dna-pk inhibitors
10/10/2007EP1841761A1 Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same
10/10/2007EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007CN100341853C Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound
10/04/2007WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007WO2007084914A3 Phenoxy-substituted pyrimidines as adenosine receptor antagonists
10/04/2007WO2007033214A3 Esters of compounds in the leptomycin family
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/03/2007EP1838304A2 Heterocyclic aspartyl protease inhibitors
10/03/2007CN101048399A 4-hetero aryl methyl substituted phthalazinone derivatives
10/03/2007CN101048383A 促性腺激素释放激素受体拮抗剂 Gonadotropin-releasing hormone receptor antagonist
10/02/2007CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
09/2007
09/27/2007WO2007107470A2 Pyrazoles as 11-beta-hsd-1
09/27/2007WO2007107385A2 Soluble adenylate cyclase inhibitors
09/27/2007WO2007085356A3 Insecticidal (heteroarylalkyl)alkane thio and oxo amine derivatives
09/27/2007US20070225361 Dimeric compounds and their use as anti-viral agents
09/27/2007CA2646650A1 Soluble adenylate cyclase inhibitors
09/26/2007EP1836183A2 Spiro derivatives as lipoxygenase inhibitors
09/26/2007EP1303520B1 Therapeutic compounds and methods
09/26/2007CN101044139A Cyclopamine analogues and methods of use thereof
09/25/2007US7273886 Benzofuran inhibitors of factor VIIa
09/25/2007US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases
09/25/2007CA2403026C Process for the preparation of 6-o-propargyl erythromycin derivatives
09/20/2007WO2007105353A1 Plant-derived therapeutic agent for malignant tumor
09/20/2007WO2007104696A1 Antimalarial agents having polyaromatic structure
09/19/2007EP1833819A1 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
09/19/2007EP1198456B1 Potassium channel openers
09/19/2007CN101037415A S-DABO compound, synthesizing method and usage
09/19/2007CN101037407A Method for the production of bisepoxides and dithiols
09/19/2007CN100337626C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/18/2007US7271168 Piperazine derivatives having SST1 antagonistic activity
09/18/2007CA2263362C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
09/13/2007WO2007102368A1 Novel 3-(1-aminoalkylidene)furan-2,4(3h,5h)-dione derivative, method for producing the same, and pharmaceutical composition containing the same as active ingredient
09/13/2007US20070213394 Salvinorin derivatives and uses thereof
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 120